Stephens Consulting, LLC Spring Works Therapeutics, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 20 shares of SWTX stock, worth $758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$758% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
241Shares Held
67.4MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$271 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$213 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$131 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$124 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$114 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.37B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...